Eevia Health

The Taiwanese customer is a large international distributor of dietary ingredients for health products. The distributor has been actively developing multi-functional natural dietary ingredients for health products, accumulating decades of R&D experience. The distributor takes a high road on quality, with a strict screening of sources of natural dietary ingredients. They have a professional approach to quality and a strong presence in the market.

The sales value to Eevia of this new order is c. KEUR 11 EUR. The product is Eevia's branded ingredient Feno-Myrtillus® 25 Organic, which is a highly concentrated and organically certified bilberry extract with 25% anthocyanins.

With the Feno-Myrtillus® Organic product line, Eevia Health is moving its focus towards the positive clinical effects observed in eye health (8 positive clinical studies, 600 subjects). A significant number of consumers are concerned with eye health, ranging from the aging Baby boomers to the younger Gen-Z population that spend a lot of time behind computer screens. Bilberry anthocyanins help visual acuity and other performance factors in the human eye.

The order is expected to be followed by further repeat orders in the future.

For further information, please contact:

Stein Ulve, CEO, Eevia Health Plc                          

Email: stein.ulve@eeviahealth.com                      

Telephone: +358 400 22 5967                         

INFORMATION ABOUT EEVIA HEALTH PLC

Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients in dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.

Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia's other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.

Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA.

To learn more, please visit  www.eeviahealth.com or follow Eevia Health on LinkedIn@EeviaHealth